Thrombotic complications in von Willebrand disease

References

• Franchini M. Thrombotic complications in patients with hereditary bleeding disorders. Thromb Haemost 2004; 92:298–304.
   PubMed Web of Science ®Google Scholar
• Nichols TC, Samama CM, Bellinger DA, et al. Function of von Willebrand factor after crossed bone marrow transplan-tation between normal and von Willebrand disease pigs: Effect on arterial thrombosis in chimeras. Proc Natl Acad Sci USA 1995;92:2455–2459.
   PubMed Web of Science ®Google Scholar
• Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Chin Invest 1998; 101:479–486.
   PubMed Web of Science ®Google Scholar
• Goto S, Sakai H, Goto M, et al. Enhanced shear-induced platelet aggregation in acute myocardial infarction. Circulation 1999;99:608–613.
   PubMed Web of Science ®Google Scholar
• Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 2003;107: 3141–3145.
   PubMed Web of Science ®Google Scholar
• van der Meer IM, Brouwers GJ, Bulk S, et al. Genetic variability of von Willebrand factor and risk of coronary heart disease: The Rotterdam Study. Br J Haematol 2004; 124:343–347.
   PubMed Web of Science ®Google Scholar
• Moake JL. Thrombotic microangiopathies. N Engl J Med 2002;347:589–600.
   PubMed Web of Science ®Google Scholar
• Sramek A, Bucciarelli P, Federici AB, et al. Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis. Results from a multicenter study in 47 patients. Circulation 2004;109:740–744.
   PubMed Web of Science ®Google Scholar
• Bowen D, Dasani H, Yung B, Bloom A. Deep venous thrombosis and pulmonary embolism in a patient with type III von Willebrand’s disease, protein C and antithrombin III deficiency. Br J Haematol 1992;81:446–447.
   PubMed Web of Science ®Google Scholar
• Franchini M, Krampera M, Veneri D. Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes. Thromb Haemost 2003;90: 963–964.
   PubMed Web of Science ®Google Scholar
• Franchini M, Veneri D. Are only hemophiliacs protected against ischemic heart disease? Thromb Haemost 2004;92:1455–1456.
   PubMed Web of Science ®Google Scholar
• Fragasso G, Camba L, Pizzetti G, Pagnotta P, Chierchia SL. Successful thrombolysis for acute myocardial infarction in type 1 von Willebrand’s disease (VWD). Am J Hematol 1998; 57: 180.
   PubMed Web of Science ®Google Scholar
• Mannucci PM. Venous thromboembolism in von Willebrand disease. Thromb Haemost 2002;88:378–379.
   PubMed Web of Science ®Google Scholar
• Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormal-ities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore) 1983;62: 248–255.
   PubMed Web of Science ®Google Scholar
• Dulhoste MN, Bonnet J, Vergnes C, Choussat A, Bricaud H. von Willebrand’s disease and coronary atherosclerosis. Apropos of 3 cases. Arch Mal Coeur Vaiss 1989; 82:1875–1878.
   PubMedGoogle Scholar
• Girolami A, Cappellato MG, Vicarioto MA, Casonato S, Marafioti F. Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento). Blut 1986;52:29–33.
   PubMedGoogle Scholar
• van Dijk K, van der Born JG, Fischer K, Grobbee DE, van der Berg HM. Do prothrombotic factors influence clinical phenotype of severe hemophilia? A review of the literature. Thromb Haemost 2004;92:305–310.
   PubMed Web of Science ®Google Scholar
• Weiss HJ. The bleeding tendency in patients with low von Willebrand factor and type 1 phenotype is greater in the presence of impaired collagen-induced platelet aggregation. J Thromb Haemost 2004;2:198–199.
   PubMed Web of Science ®Google Scholar
• Kunicki TJ, Federici AB, Salomon DR, et al. An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood 2004;104:2359–2367.
   PubMed Web of Science ®Google Scholar
• Makris M, Colvin B, Gupta V, Shields ML, Smith MP. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand’s disease. Thromb Haemost 2002;88:387–388.
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Chediak J, Hanna W, Byrnes J, Marlies L, Ewenstein BM. and the Alphanate Study Group Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: A prospective, multicenter study. Blood 2002;99:450–456.
   PubMed Web of Science ®Google Scholar
• Franchini M, Rossetti G, Tagliaferri A, et al. Efficacy and safety of factor VIII/ von Willebrand factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand’s disease. Haematologica 2003;88:1279–1283.
   PubMed Web of Science ®Google Scholar
• Rosendaal FR. High levels of factor VIII and venous thrombosis. Thromb Haemost 2000;83:1–2.
   PubMed Web of Science ®Google Scholar
• Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR, Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345:152–155.
   PubMed Web of Science ®Google Scholar
• Mannucci PM. Treatment of von Willebrand’s disease. N Engl J Med 2004;351:683–694.
   PubMed Web of Science ®Google Scholar
• Basso IN, Keeling D. Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease. Blood Coagul Fibrinolysis 2004; 15:503–504.
   PubMed Web of Science ®Google Scholar
• Sadler JE. New concepts in von Willebrand disease. Annu Rev Med 2005;56:173–191.
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM. Type IIB von Willebrand disease: A paradox explains how von Willebrand factor works. J Thromb Haemost 2004;2:2–6.
   PubMed Web of Science ®Google Scholar
• Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996;84:289–297.
   PubMed Web of Science ®Google Scholar
• Miura S, Li CQ, Cao Z, Wang H, Wardell MR, Sadler JE. Interaction of von Willebrand factor domain Al with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion. J Biol Chem 2000; 275:7539–7546.
   PubMed Web of Science ®Google Scholar
• Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet 1999;353:1167–1173.
   PubMed Web of Science ®Google Scholar